UPDATE: JP Morgan Initiates Greenway Medical Technologies at Overweight on Platform Quality

JP Morgan initiated coverage on Greenway Medical Technologies

with an Overweight rating and a $19 price target. JP Morgan noted, "We are initiating coverage on Greenway (GWAY) with an Overweight rating as we believe the company has a highly rated, differentiated platform from which to gain additional EMR, RCM and PM customers. Additionally, we believe Greenway's pro-active partnerships with enterprise EHRs provide an advantage for physicians." Greenway Medical Technologies closed at $15.98 on Wednesday.